PHK
ZNTL icon

Point72 Hong Kong’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Point72 Hong Kong’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,740
Closed -$59K – 1738
2022
Q3 		$59K Buy
+2,740
New +$74.9K ﹤0.01% 1383
2022
Q2 		– Sell
-1,567
Closed -$72K – 2478
2022
Q1 		$72K Buy
+1,567
New +$84.5K ﹤0.01% 1243
2021
Q3 		– Sell
-4,422
Closed -$235K – 2510
2021
Q2 		$235K Buy
+4,422
New +$237K 0.01% 1112
2021
Q1 		– Sell
-320
Closed -$17K – 2269
2020
Q4 		$17K Buy
+320
New +$14.4K ﹤0.01% 1460

Other funds holding ZNTL

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Point72 Hong Kong's ZNTL Position: Q4 2022 in Review

Point72 Hong Kong sold out of Zentalis Pharmaceuticals (ZNTL) in Q4 2022, closing a stake of 2,740 shares — an estimated $59K sold.

Point72 Hong Kong first reported a position in ZNTL in Q4 2020 and held it in 4 quarters. The position peaked at $235K in Q2 2021. 106 funds tracked by Wall St. Rank hold ZNTL as of Q4 2022.

  • Point72 Hong Kong reported no remaining Zentalis Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 2,740 Zentalis Pharmaceuticals shares in Q4 2022, an estimated $59K.
  • Point72 Hong Kong first reported a position in Zentalis Pharmaceuticals in Q4 2020 and held it in 4 quarters.
  • Point72 Hong Kong's Zentalis Pharmaceuticals position peaked at $235K in Q2 2021.
  • 106 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.